Hexarelin Therapy: Complete Guide
Hexarelin is a synthetic hexapeptide growth hormone secretagogue in the GHRP family, related to GHRP-6 and ipamorelin. It stimulates growth hormone release through the ghrelin receptor and has also been studied for direct effects on cardiac tissue. It is not approved for any human use. A recognised limitation is that its growth hormone response attenuates with continued administration.
Fact-checking at PeptideProbe is editorial, not clinical. Our editors check claims, dosing figures, and trial results against primary sources; they are not licensed clinicians and do not provide medical review. Nothing here is medical advice — talk to a qualified healthcare provider before starting any therapy.
What is Hexarelin?
Hexarelin is a synthetic hexapeptide growth hormone secretagogue in the GHRP family, related to GHRP-6 and ipamorelin. It stimulates growth hormone release through the ghrelin receptor and has also been studied for direct effects on cardiac tissue. It is not approved for any human use. A recognised limitation is that its growth hormone response attenuates with continued administration.
How Hexarelin Works
Hexarelin works through specific biological pathways to produce its therapeutic effects. Consult with a qualified provider for detailed information about how this peptide therapy works for your specific condition.
Benefits & Uses
Potent stimulation of growth hormone release in study settings, with additional cardiovascular effects reported independent of growth hormone. Investigated but never approved.
Clinical Evidence & Research
Clinical research on Hexarelin continues to evolve. Hexarelin has been studied in preclinical and clinical settings. Speak with your provider about the current evidence base.
Side Effects & Safety
Increases in cortisol and prolactin have been reported, more so than with more selective secretagogues such as ipamorelin. Desensitisation of the growth hormone response with continued use is documented. Water retention and joint discomfort are commonly reported with growth hormone secretagogues generally.
Dosing & Administration
Dosing protocols for Hexarelin should be determined by a qualified healthcare provider based on your individual health profile, treatment goals, and response to therapy. Self-dosing without medical supervision is not recommended.
Find Hexarelin Providers Near You
Search our directory for qualified providers offering Hexarelin therapy. Filter by location, telehealth, and more.
Browse ProvidersHexarelin FAQ
Potent stimulation of growth hormone release in study settings, with additional cardiovascular effects reported independent of growth hormone. Investigated but never approved.
Costs vary by provider and location. Contact providers directly for current pricing.
Hexarelin has an FDA status of "Research". It is currently used in research and clinical settings. Consult with a qualified provider about its regulatory status and appropriate use.
Increases in cortisol and prolactin have been reported, more so than with more selective secretagogues such as ipamorelin. Desensitisation of the growth hormone response with continued use is documented. Water retention and joint discomfort are commonly reported with growth hormone secretagogues generally.
PeptideProbe lists 0 providers offering Hexarelin therapy. Use our directory to search by location, filter by telehealth availability, and compare providers.
What Hexarelin is used for
Each of these reviews the evidence for that goal, including where it is weaker than the marketing suggests.
Stay Updated
Get notified when new peptide therapy providers join in your area.
Related Peptides
Medical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.